Beijing Shijitan Hospital, Capital Medical University

Beijing 100038

3 studies enrolling now · 4 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Blood Pressure, Major Surgery

Studies at this site

• The GUARDIAN Trial — Recruiting now
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• The GUARDIAN Trial - Induction Agent Sub-Study — Enrolling by invitation
• The GUARDIAN Trial - Vasopressor Sub-Study — Enrolling by invitation